Our patented WINDOW INTO THE BRAIN technology can test human and animal model blood samples across several neurogenerative disease states
Provides data to monitor disease activity and therapeutic effectiveness. Aligning the MS patient with the optimal medication can aid in slowing disease progression while reducing healthcare costs.
May reveal biomarker expression patterns that predict who will have a concussion that simply resolves and who will develop late sequelae from this injury, such as chronic traumatic encephalopathy (CTE).
Targeted to provide the patient with an early diagnosis allowing for early treatment and the prospect of controlling the disease before symptoms arise.
Copyright © 2021 ZelosDx - All Rights Reserved.